These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 23008442

  • 1. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Brooks MM, Chaitman BR, Nesto RW, Hardison RM, Feit F, Gersh BJ, Krone RJ, Sako EY, Rogers WJ, Garber AJ, King SB, Davidson CJ, Ikeno F, Frye RL, BARI 2D Study Group.
    Circulation; 2012 Oct 23; 126(17):2115-24. PubMed ID: 23008442
    [Abstract] [Full Text] [Related]

  • 2. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
    Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.
    Circulation; 2009 Dec 22; 120(25):2529-40. PubMed ID: 19920001
    [Abstract] [Full Text] [Related]

  • 3. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ, Novak E, Brown DL.
    Coron Artery Dis; 2017 Jun 22; 28(4):301-306. PubMed ID: 28346285
    [Abstract] [Full Text] [Related]

  • 4. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
    Schwartz L, Kip KE, Alderman E, Lu J, Bates ER, Srinivas V, Bach RG, Mighton LD, Feit F, King S, Frye RL, BARI 2D Study Group.
    Am J Cardiol; 2009 Mar 01; 103(5):632-8. PubMed ID: 19231325
    [Abstract] [Full Text] [Related]

  • 5. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, Mighton L, Jacobs AK, BARI 2D Study Group.
    J Am Coll Cardiol; 2013 Apr 30; 61(17):1767-76. PubMed ID: 23500245
    [Abstract] [Full Text] [Related]

  • 6. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Dagenais GR, Lu J, Faxon DP, Kent K, Lago RM, Lezama C, Hueb W, Weiss M, Slater J, Frye RL, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.
    Circulation; 2011 Apr 12; 123(14):1492-500. PubMed ID: 21444887
    [Abstract] [Full Text] [Related]

  • 7. SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
    Ikeno F, Brooks MM, Nakagawa K, Kim MK, Kaneda H, Mitsutake Y, Vlachos HA, Schwartz L, Frye RL, Kelsey SF, Waseda K, Hlatky MA, BARI-2D Study Group.
    J Am Coll Cardiol; 2017 Jan 31; 69(4):395-403. PubMed ID: 28126156
    [Abstract] [Full Text] [Related]

  • 8. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.
    Kim LJ, King SB, Kent K, Brooks MM, Kip KE, Abbott JD, Jacobs AK, Rihal C, Hueb WA, Alderman E, Sing IR, Attubato MJ, Feit F, BARI 2D (Bypass Angioplasty Revascularization Investigation Type 2 Diabetes) Study Group.
    JACC Cardiovasc Interv; 2009 May 31; 2(5):384-92. PubMed ID: 19463459
    [Abstract] [Full Text] [Related]

  • 9. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
    Khan AA, Chung MJ, Novak E, Brown DL.
    J Am Heart Assoc; 2017 Sep 13; 6(9):. PubMed ID: 28903941
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL, BARI 2D Investigators.
    Circulation; 2013 Aug 20; 128(8):785-94. PubMed ID: 23857320
    [Abstract] [Full Text] [Related]

  • 11. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Hlatky MA, Boothroyd DB, Melsop KA, Kennedy L, Rihal C, Rogers WJ, Venkitachalam L, Brooks MM, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.
    Circulation; 2009 Dec 22; 120(25):2550-8. PubMed ID: 19920002
    [Abstract] [Full Text] [Related]

  • 12. Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Brooks MM, Chung SC, Helmy T, Hillegass WB, Escobedo J, Melsop KA, Massaro EM, McBane RD, Hyde P, Hlatky MA, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.
    Circulation; 2010 Oct 26; 122(17):1690-9. PubMed ID: 20937978
    [Abstract] [Full Text] [Related]

  • 13. Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D).
    Schwartz L, Bertolet M, Feit F, Fuentes F, Sako EY, Toosi MS, Davidson CJ, Ikeno F, King SB.
    Circ Cardiovasc Interv; 2012 Apr 26; 5(2):166-73. PubMed ID: 22496082
    [Abstract] [Full Text] [Related]

  • 14. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM, Boden WE, Frye RL.
    Coron Artery Dis; 2010 Nov 26; 21(7):383-5. PubMed ID: 20664331
    [Abstract] [Full Text] [Related]

  • 15. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF, Stables RH, Stone GW, Serruys PW, Kappetein AP.
    J Am Coll Cardiol; 2018 Jul 24; 72(4):386-398. PubMed ID: 30025574
    [Abstract] [Full Text] [Related]

  • 16. Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Shah B, Srinivas VS, Lu J, Brooks MM, Bates ER, Nedeljkovic ZS, Escobedo J, Das GS, Lopez JJ, Feit F.
    Am Heart J; 2013 Sep 24; 166(3):519-26. PubMed ID: 24016502
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of therapies for type 2 diabetes and coronary artery disease.
    BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE.
    N Engl J Med; 2009 Jun 11; 360(24):2503-15. PubMed ID: 19502645
    [Abstract] [Full Text] [Related]

  • 18. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Shaw LJ, Cerqueira MD, Brooks MM, Althouse AD, Sansing VV, Beller GA, Pop-Busui R, Taillefer R, Chaitman BR, Gibbons RJ, Heo J, Iskandrian AE.
    J Nucl Cardiol; 2012 Aug 11; 19(4):658-69. PubMed ID: 22527794
    [Abstract] [Full Text] [Related]

  • 19. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A, Bartolini D, Finlay MC, Qureshi AC, Flather M, Strange JW, Hall RJ.
    J Cardiovasc Med (Hagerstown); 2010 Jan 11; 11(1):26-33. PubMed ID: 19797974
    [Abstract] [Full Text] [Related]

  • 20. Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).
    Whitlow PL, Dimas AP, Bashore TM, Califf RM, Bourassa MG, Chaitman BR, Rosen AD, Kip KE, Stadius ML, Alderman EL.
    J Am Coll Cardiol; 1999 Nov 15; 34(6):1750-9. PubMed ID: 10577566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.